+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
From
From
From
From
From
From
From
From
From
From
From
Cancer Cell Analysis Market Report 2025 - Product Thumbnail Image

Cancer Cell Analysis Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Rare Disease Genome Editing Market Report 2025 - Product Thumbnail Image

Rare Disease Genome Editing Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Personalized Medicine Bioinformatics Market Report 2025 - Product Thumbnail Image

Personalized Medicine Bioinformatics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Omics Lab Services Market Report 2025 - Product Thumbnail Image

Omics Lab Services Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Precision Genomic Testing Market Report 2025 - Product Thumbnail Image

Precision Genomic Testing Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more